Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Follow-up of the first depressive episode: prevalence and factors associated with the development of recurrent depressive disorder and bipolar affective disorder

https://doi.org/10.14412/2074-2711-2026-3-49-56

Abstract

The high prevalence and tendency to relapse associated with depressive disorders highlight the need to investigate the long-term outcomes of a first depressive episode.

Objective: to determine the prevalence and identify the factors associated with the development of recurrent depressive disorder (RDD) and bipolar affective disorder (BAD) following inpatient treatment for a first depressive episode.

Material and methods. A retrospective cohort study was conducted involving 237 patients hospitalised with a first depressive episode between 2013 and 2017. The follow-up period was up to 12 years.

Results. RDD developed in 20.3% of patients, and BAD in 12.2%. Factors associated with the development of RDD included older age (median 51 years; p=0.034), chronic psychological trauma (p=0.016), episode duration of more than 60 days prior to hospitalisation (p<0.001) and a family history of mental illness (p<0.001). Factors associated with the development of BAD were younger age (median – 35 years; p=0.043), male gender (p<0.001), a disharmonic premorbid personality (p<0.001), a history of mood swings (p=0.002), alcohol abuse (p<0.001) and a family history of mental illness (p<0.001). An early (within 6 months) exacerbation was associated with a short first hospital stay (median – 15 days; p<0.001) and irregular adherence to maintenance therapy (p<0.001).

Conclusion. One in three patients develops chronic affective disorder following their first depressive episode. The identified prognostic markers make it possible to identify high-risk groups for RDD and BAD as early as the first hospitalisation, thereby enabling the personalisation of treatment strategies.

About the Authors

T. V. Bogatov
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

8, Trubetskaya St., Moscow 119048 


Competing Interests:

There are no conflicts of interest.  



Yu. G. Tikhonova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

Yulia Gulyamovna Tikhonova 

8, Trubetskaya St., Moscow 119048 


Competing Interests:

There are no conflicts of interest.  



M. N. Efremova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

8, Trubetskaya St., Moscow 119048 


Competing Interests:

There are no conflicts of interest.  



N. N. Ivanets
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

8, Trubetskaya St., Moscow 119048 


Competing Interests:

There are no conflicts of interest.  



M. A. Kinkulkina
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

8, Trubetskaya St., Moscow 119048 


Competing Interests:

There are no conflicts of interest.  



References

1. Global Burden of Disease (GBD) [online database]. Seattle: Institute for Health Metrics and Evaluation; 2024. Available at: https://vizhub.healthdata.org/gbd-results/ (accessed 25.05.2026).

2. GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137-50. doi: 10.1016/S2215-0366(21)00395-3

3. Hardeveld F, Spijker J, De Graaf R, et al. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand. 2010 Sep;122(3):184-91. doi: 10.1111/j.1600-0447.2009.01519.x

4. Upthegrove R. Depression in schizophrenia and early psychosis: implications for assessment and treatment. Adv Psychiatr Treat. 2009;15(5):372-9. doi: 10.1192/apt.bp.108.005629

5. Pacek LR, Martins SS, Crum RM. The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample. J Affect Disord. 2013;148(2-3):188-95. doi: 10.1016/j.jad.2012.11.059

6. Kuo CY, Stachiv I, Nikolai T. Association of late life depression, (non-) modifiable risk and protective factors with dementia and Alzheimer's disease: literature review on current evidences, preventive interventions and possible future trends in prevention and treatment of dementia. Int J Environ Res Public Health. 2020 Oct 14;17(20):7475. doi: 10.3390/ijerph17207475

7. Hardeveld F, Spijker J, De Graaf R, et al. Recurrence of major depressive disorder and its predictors in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med. 2013;43:39-48. doi: 10.1017/S0033291712002395

8. Eaton WW, Shao H, Nestadt G, et al. Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psychiatry. 2008;65(5):513-20. doi: 10.1001/archpsyc.65.5.513

9. Mattisson C, Bogren M, Horstmann V, et al. The long-term course of depressive disorders in the Lundby Study. Psychol Med. 2007;37:883-91. doi: 10.1017/S0033291707000074

10. Hollon SD, Shelton RC, Wisniewski S, et al. Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial. J Psychiatr Res. 2006;40(1):59-69. doi: 10.1016/j.jpsychres.2005.07.008

11. Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry. 2000;157:229-33.

12. O’Donovan C, Alda M. Depression preceding diagnosis of bipolar disorder. Front Psychiatry. 2020 Apr 24;11:500. doi: 10.3389/fpsyt.2020.00500

13. Perugi G, Pacchiarotti I, Mainardi C, et al. Patterns of response to antidepressants in major depressive disorder: drug resistance or worsening of depression are associated with a bipolar diathesis. Eur Neuropsychopharmacol. 2019 Jul;29(7):825-34. doi: 10.1016/j.euroneuro.2019.06.001

14. Gannushkin PB. Clinic of Psychopathies, Their Statics, Dynamics, Systematics. Moscow: Sever; 1933. 143 p. (In Russ.).

15. Lichko AE. Psychopathies and Character Accentuations in Adolescents. Leningrad: Meditsina; 1983. 256 p. (In Russ.).

16. Nöbbelin L, Bogren M, Mattisson C, Bradvik L. Risk factors for recurrence in depression in the Lundby population, 1947–1997. J Affect Disord. 2018;228:125-31.

17. Moffitt TE, Caspi A, Taylor A, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med. 2010;40:899-909. doi: 10.1017/S0033291709991036

18. Lim GY, Tam WW, Lu Y, et al. Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep. 2018 Feb 12;8(1):2861. doi: 10.1038/s41598-018-21243-x

19. Monroe SM, Harkness KL. Major depression and its recurrences: life course matters. Annu Rev Clin Psychol. 2022 May 9;18:329-57. doi: 10.1146/annurev-clinpsy-072220-021440

20. Baryshnikov I, Sund R, Marttunen M, et al. Diagnostic conversion from unipolar depression to bipolar disorder, schizophrenia, or schizoaffective disorder: a nationwide prospective 15-year register study on 43 495 inpatients. Bipolar Disord. 2020 Sep;22(6):582- 92. doi: 10.1111/bdi.12929

21. Nestsiarovich A, Reps JM, Matheny ME, et al. Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network study. Transl Psychiatry. 2021 Dec 20;11(1):642. doi: 10.1038/s41398-021-01760-6

22. Donner NC, Lowry CA. Sex differences in anxiety and emotional behavior. Pflugers Arch. 2013;465:601-26. doi: 10.1007/s00424-013-1271-7


Review

For citations:


Bogatov TV, Tikhonova YG, Efremova MN, Ivanets NN, Kinkulkina MA. Follow-up of the first depressive episode: prevalence and factors associated with the development of recurrent depressive disorder and bipolar affective disorder. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2026;18(3):49-56. (In Russ.) https://doi.org/10.14412/2074-2711-2026-3-49-56

Views: 146

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)